David Jackson
Corporate Officer/Principal chez Royal College of General Practitioners
Profil
David Jackson is a professional with a doctorate and undergraduate degree from the University of Glasgow.
He is currently a member of the Royal College of General Practitioners.
Previously, he held positions as Principal at Wyeth Holdings LLC and A.H.
Robins Co., Inc. He was also the Chief Medical Officer and SVP-Research & Development at Adolor Corp.
from 2001 to 2008.
From 1994 to 2001, he was the President & Chief Medical Officer at Theorem Clinical Research, Inc. He was the Vice President-Clinical Research & Development at The Janssen Research Foundation from 1988 to 1994.
Additionally, he was the Chief Medical Officer at Relevare Aust Pty Ltd.
and Relevare Pharmaceuticals Ltd.
Postes actifs de David Jackson
| Sociétés | Poste | Début |
|---|---|---|
Royal College of General Practitioners
 Royal College of General Practitioners Other Consumer ServicesConsumer Services The Royal College of General Practitioners is a professional membership body for family doctors in the UK and overseas. The non-profit company is based in London, UK and has subsidiaries in the United Kingdom. The British company is committed to improving patient care and clinical standards. The RCGP offers a fellowship program, which is the highest level of membership and exemplifies their motto "cum scientia caritas". The company also provides accreditation for high-quality resources and activities relevant to general practitioners. The Daffodil Standards is a free, evidence-based framework to help practices self-assess and consistently offer the best end of life and bereavement care. The RCGP represents the interests of established GPs and acts as a conduit for local matters to be raised at national meetings. | Corporate Officer/Principal | 18/08/2011 |
Anciens postes connus de David Jackson
| Sociétés | Poste | Fin |
|---|---|---|
Adolor Corp.
 Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Directeur Technique/Scientifique/R&D | 22/05/2008 |
Theorem Clinical Research, Inc.
 Theorem Clinical Research, Inc. Medical/Nursing ServicesHealth Services Theorem Clinical Research, Inc. is a contract research organization that provides core clinical research and development services. The company was founded in 1985 and is headquartered in King of Prussia, PA. | President | 01/01/2001 |
| The Janssen Research Foundation | Directeur Technique/Scientifique/R&D | 01/01/1994 |
| A.H. Robins Co., Inc. | Corporate Officer/Principal | - |
Relevare Pharmaceuticals Ltd.
 Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Directeur Technique/Scientifique/R&D | - |
Formation de David Jackson
| University of Glasgow | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Adolor Corp.
Adolor Corp. BiotechnologyHealth Technology Adolor Corp. is a biopharmaceutical company specializing in the discovery, development and commercialization of novel prescription pain management products. The company develops and commercializes of novel opioid receptor-targeted therapeutics designed to maintain or improve pain relief and reduce opioid-related side effects. Its commercial product ENTEREG is a small molecule, peripherally acting mu opioid receptor antagonist intended to block the adverse side effects of opioid analgesics like morphine, on the gastrointestinal tract without interfering with central nervous system and mediated analgesia. The company was founded in 1993 and is headquartered in Exton, PA. | Health Technology |
| The Janssen Research Foundation | |
Theorem Clinical Research, Inc.
Theorem Clinical Research, Inc. Medical/Nursing ServicesHealth Services Theorem Clinical Research, Inc. is a contract research organization that provides core clinical research and development services. The company was founded in 1985 and is headquartered in King of Prussia, PA. | Health Services |
Relevare Aust Pty Ltd.
 Relevare Aust Pty Ltd. Pharmaceuticals: MajorHealth Technology Relevare Aust Pty Ltd. develops innovative methods to treat diseases. The company was founded on August 9, 2004 and is headquartered in Abbotsford, Australia. | Health Technology |
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Process Industries |
Relevare Pharmaceuticals Ltd.
Relevare Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia. | Health Technology |
| A.H. Robins Co., Inc. | Distribution Services |
Royal College of General Practitioners
Royal College of General Practitioners Other Consumer ServicesConsumer Services The Royal College of General Practitioners is a professional membership body for family doctors in the UK and overseas. The non-profit company is based in London, UK and has subsidiaries in the United Kingdom. The British company is committed to improving patient care and clinical standards. The RCGP offers a fellowship program, which is the highest level of membership and exemplifies their motto "cum scientia caritas". The company also provides accreditation for high-quality resources and activities relevant to general practitioners. The Daffodil Standards is a free, evidence-based framework to help practices self-assess and consistently offer the best end of life and bereavement care. The RCGP represents the interests of established GPs and acts as a conduit for local matters to be raised at national meetings. | Consumer Services |
